Amethyst 28 Day Shortage: What Providers and Prescribers Need to Know in 2026

Patients prescribed Amethyst 28 Day (levonorgestrel 90 mcg / ethinyl estradiol 20 mcg) are increasingly reporting difficulty filling their prescriptions at local pharmacies. While there is no FDA-declared national shortage of this product as of 2026, localized stocking issues are real — and they're generating calls to prescriber offices from patients who need guidance. This guide helps clinicians navigate the situation efficiently.

The Clinical Context: Why Amethyst 28 Day Is Prescribed

Amethyst 28 Day is the only remaining commercially available continuous-cycle oral contraceptive of its exact formulation — the generic successor to Lybrel (discontinued). Its defining characteristic is that all 28 tablets are active hormone tablets. There is no tablet-free interval, meaning patients on Amethyst 28 Day:

Do not experience scheduled withdrawal bleeding (periods)

May experience unscheduled bleeding or spotting, especially in the first 6 months

Are often prescribed this formulation specifically to manage endometriosis, PMDD, dysmenorrhea, or for personal preference regarding menstrual suppression

This clinical context is critical when considering therapeutic substitution. Switching a patient to a standard 28-day pack with a placebo week may re-introduce breakthrough bleeding or cycle-dependent symptom recurrence that was specifically being managed by continuous dosing.

Why Are Pharmacies Running Low on Amethyst 28 Day?

Several supply-side factors are contributing to inconsistent availability:

Niche market position. Continuous-cycle oral contraceptives represent a small fraction of combined OCP prescriptions. Pharmacies order based on turnover; slow movers get undersupplied.

Brand reference discontinued. Lybrel's discontinuation reduced institutional awareness of the continuous 90/20 formulation among pharmacy staff, affecting ordering patterns.

Wholesaler and formulary variability. When a PBM or pharmacy chain shifts its preferred levonorgestrel/ethinyl estradiol contract from Amethyst to another branded generic, Amethyst gets deprioritized in ordering.

Therapeutic Substitution Options: A Clinical Framework

When Amethyst 28 Day is unavailable and a patient cannot wait, consider the following alternatives based on clinical indication:

If Period Suppression Is the Primary Goal

Extended-cycle LNG/EE (Seasonique, Jolessa, Simpesse): 84 active tablets + 7 low-dose estrogen or placebo tablets. Reduces periods to approximately 4 per year. A clinically defensible bridge for patients who cannot tolerate monthly withdrawal bleeds.

Levonorgestrel IUD (Mirena, Kyleena): Many patients experience amenorrhea after the first year. A good long-term option for patients who want to avoid the oral route and desire durable menstrual suppression.

Etonogestrel implant (Nexplanon): Highly effective; many patients see reduced or absent bleeding, though effects are less predictable than with continuous COCs.

If Contraception Only (Period Suppression Not Essential)

Standard LNG/EE 28-day packs (Portia 0.15/0.03, Aviane 0.1/0.02): Widely stocked, same pharmacological class, requires new Rx. The placebo week reintroduces a withdrawal bleed — clinically acceptable for contraception-only patients.

Norgestimate/EE (Sprintec, Tri-Sprintec): One of the most widely dispensed oral contraceptives in the U.S. Excellent availability and well-tolerated side effect profile. Requires new Rx (different active ingredient).

Drospirenone/EE (Yaz, Syeda, Nikki): Appropriate for patients with acne or PMDD. Note the slightly higher VTE risk compared to LNG-based products in some analyses.

Prescriber Workflow Recommendations

To reduce the administrative burden from Amethyst 28 Day availability calls, consider these workflow adjustments:

Write 90-day supplies. Patients who receive a 90-day supply reduce their refill touchpoints from 12 to 4 per year, significantly reducing stock exposure and callback volume.

Route to mail-order pharmacy. Mail-order pharmacies maintain larger inventory of niche formulations. Consider making this the default dispensing route for Amethyst 28 Day patients.

Pre-authorize a therapeutic alternative. Indicate on the prescription that a specific therapeutic alternative is acceptable if Amethyst 28 Day is unavailable, so patients don't need to call back for a new Rx.

Recommend medfinder to patients. medfinder contacts pharmacies near the patient and texts them results — dramatically reducing the number of patient calls your staff receives about where to fill their prescription.

Counseling Patients on Gaps in Coverage

Patients who miss doses of a continuous OCP face elevated pregnancy risk. Key counseling points:

Use barrier contraception (condoms) if there is any gap in pill-taking, until the active pill has been taken consistently for 7 days

Emergency contraception (Plan B, Ella) is available OTC if unprotected sex occurred during the gap

Do not have patients "double up" on missed days beyond what the package insert specifies without pharmacist/clinical guidance

Summary for Prescribers

Amethyst 28 Day is available nationally but stocked inconsistently at the local pharmacy level. By writing 90-day supplies, routing to mail-order, pre-authorizing alternatives, and recommending that patients use medfinder to locate in-stock pharmacies, prescribers can significantly reduce care disruption and administrative burden for both patients and their office staff.